跳至主要内容
临床试验/NCT01487408
NCT01487408已完成不适用

Special Survey for Type 1 or Type 2 Diabetic Patients

Novo Nordisk A/S0 个研究点目标入组 1,463 人开始时间: 2002年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
1,463
主要终点
HbA1c (glycosylated haemoglobin)

研究概览

简要总结

This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia episodes under normal clinical practice for patients with type 1 or type 2 diabetes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with diabetes requiring insulin therapy

排除标准

  • Patients who had not been treated more than 3 months at the same investigational site
  • Patients who had treatment history of NovoRapid® (insulin aspart)

研究组 & 干预措施

Insulin Aspart

干预措施: insulin aspart (Drug)

结局指标

主要结局

HbA1c (glycosylated haemoglobin)

次要结局

  • Incidence of servere hypoglycaemia
  • Total dose of insulin (aspart/human insulin) infused subcutaneously
  • Physical examination
  • Adverse events

研究者

申办方类型
Industry
责任方
Sponsor

相似试验